• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain.全长PCSK9在1.9埃分辨率下的自抑制结构揭示了其C端结构域与抵抗素的结构同源性。
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14604-9. doi: 10.1073/pnas.0703402104. Epub 2007 Sep 5.
2
Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.基于弗林蛋白酶和凯新蛋白酶晶体结构的前体蛋白转化酶模型:对其特异性的解释。
J Mol Biol. 2005 Jan 14;345(2):211-27. doi: 10.1016/j.jmb.2004.10.050.
3
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor.一种抑制前蛋白转化酶枯草溶菌素9(PCSK9)蛋白与低密度脂蛋白受体结合的小肽的鉴定。
J Biol Chem. 2014 Jan 10;289(2):942-55. doi: 10.1074/jbc.M113.514067. Epub 2013 Nov 13.
4
An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo.针对 PCSK9 羧基末端结构域的抗体可降低体内 LDL 胆固醇水平。
J Mol Biol. 2014 Feb 20;426(4):843-52. doi: 10.1016/j.jmb.2013.11.011. Epub 2013 Nov 16.
5
Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.不同营养状况的冠心病患者中抵抗素与前蛋白转化酶枯草溶菌素9水平的关系。
J Endocrinol Invest. 2015 Dec;38(12):1291-9. doi: 10.1007/s40618-015-0310-y. Epub 2015 May 24.
6
New hypotheses about the structure-function of proprotein convertase subtilisin/kexin type 9: analysis of the epidermal growth factor-like repeat A docking site using WaterMap.关于前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 的结构-功能的新假说:使用 WaterMap 分析表皮生长因子样重复 A 对接位点。
Proteins. 2010 Sep;78(12):2571-86. doi: 10.1002/prot.22767.
7
Regulatory effects of peptides from the pro and catalytic domains of proprotein convertase subtilisin/kexin 9 (PCSK9) on low-density lipoprotein receptor (LDL-R).前蛋白转化酶枯草溶菌素 9(PCSK9)原肽和催化结构域肽对低密度脂蛋白受体(LDL-R)的调节作用。
Curr Med Chem. 2010;17(20):2168-82. doi: 10.2174/092986710791299948.
8
PCSK9 as a therapeutic target of dyslipidemia.前蛋白转化酶枯草溶菌素9作为血脂异常的治疗靶点。
Expert Opin Ther Targets. 2009 Jan;13(1):19-28. doi: 10.1517/14728220802600715.
9
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.衔接蛋白 1 是蛋白水解酶原转化酶枯草溶菌素/柯萨奇蛋白酶 9 的结合伴侣,并且对于蛋白水解酶原转化酶枯草溶菌素/柯萨奇蛋白酶 9 降解低密度脂蛋白受体是必需的。
Eur Heart J. 2020 Jan 7;41(2):239-252. doi: 10.1093/eurheartj/ehz566.
10
Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion.对前蛋白转化酶枯草溶菌素9(PCSK9)进化保守性的研究揭示了一个功能上重要的突出结构。
FEBS J. 2008 Aug;275(16):4121-33. doi: 10.1111/j.1742-4658.2008.06553.x. Epub 2008 Jul 9.

引用本文的文献

1
PCSK9 Enhances Cardiac Fibrogenesis via the Activation of Toll-like Receptor and NLRP3 Inflammasome Signaling.前蛋白转化酶枯草溶菌素9通过激活Toll样受体和NLRP3炎性小体信号通路增强心脏纤维化。
Int J Mol Sci. 2025 Feb 23;26(5):1921. doi: 10.3390/ijms26051921.
2
Emerging roles of PCSK9 in kidney disease: lipid metabolism, megalin regulation and proteinuria.前蛋白转化酶枯草溶菌素9在肾脏疾病中的新作用:脂质代谢、巨膜蛋白调节和蛋白尿。
Pflugers Arch. 2025 Jun;477(6):773-786. doi: 10.1007/s00424-025-03069-5. Epub 2025 Feb 18.
3
PCSK9 in T-cell function and the immune response.前蛋白转化酶枯草溶菌素9在T细胞功能和免疫反应中的作用
Biomark Res. 2024 Dec 31;12(1):163. doi: 10.1186/s40364-024-00712-8.
4
The Biology and Clinical Implications of PCSK7.前蛋白转化酶枯草溶菌素7的生物学特性及临床意义
Endocr Rev. 2025 Mar 11;46(2):281-299. doi: 10.1210/endrev/bnae031.
5
Inhibition of PCSK9: A Promising Enhancer for Anti-PD-1/PD-L1 Immunotherapy.抑制前蛋白转化酶枯草溶菌素9:抗程序性死亡蛋白1/程序性死亡配体1免疫疗法的一种有前景的增强剂
Research (Wash D C). 2024 Sep 25;7:0488. doi: 10.34133/research.0488. eCollection 2024.
6
SPRING licenses S1P-mediated cleavage of SREBP2 by displacing an inhibitory pro-domain.SPRING 通过置换一个抑制性前结构域来介导 SREBP2 的 S1P 介导的切割。
Nat Commun. 2024 Jul 9;15(1):5732. doi: 10.1038/s41467-024-50068-8.
7
The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol.载脂蛋白 C-III 在心力衰竭和其他心血管疾病中的作用:除了对 LDL 胆固醇的影响之外的作用机制。
Heart Fail Rev. 2024 Sep;29(5):917-937. doi: 10.1007/s10741-024-10409-7. Epub 2024 Jun 18.
8
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review).PCSK9 在各种代谢状态下对血栓形成和止血的影响:脂质及其他(综述)。
Int J Mol Med. 2024 Jun;53(6). doi: 10.3892/ijmm.2024.5381. Epub 2024 May 17.
9
Immune Homeostasis Maintenance Through Advanced Immune Therapeutics to Target Atherosclerosis.通过先进的免疫治疗靶向动脉粥样硬化来维持免疫稳态。
Methods Mol Biol. 2024;2782:25-37. doi: 10.1007/978-1-0716-3754-8_2.
10
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.靶向前蛋白转化酶枯草溶菌素 9(PCSK9):从实验室到临床。
Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol.前蛋白转化酶枯草溶菌素9(PCSK9)的晶体结构:血浆低密度脂蛋白胆固醇的调节剂
Structure. 2007 May;15(5):545-52. doi: 10.1016/j.str.2007.04.004.
3
Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.pH值和低密度脂蛋白(LDL)对前蛋白转化酶枯草溶菌素9(PCSK9)依赖性低密度脂蛋白受体调节的影响。
J Biol Chem. 2007 Jul 13;282(28):20502-12. doi: 10.1074/jbc.M701634200. Epub 2007 May 10.
4
The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.分泌性前体蛋白转化酶PCSK9的细胞运输及其对低密度脂蛋白受体(LDLR)的依赖性。
Traffic. 2007 Jun;8(6):718-32. doi: 10.1111/j.1600-0854.2007.00562.x. Epub 2007 Apr 25.
5
Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.与家族性高胆固醇血症相关的前蛋白转化酶枯草溶菌素9(PCSK9)及其突变体的结构和生物物理研究。
Nat Struct Mol Biol. 2007 May;14(5):413-9. doi: 10.1038/nsmb1235. Epub 2007 Apr 15.
6
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.分泌型前蛋白转化酶枯草溶菌素9(PCSK9)可减少联体小鼠肝细胞及肝脏中低密度脂蛋白受体的数量。
J Clin Invest. 2006 Nov;116(11):2995-3005. doi: 10.1172/JCI29383.
7
Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote.前蛋白转化酶枯草溶菌素9(PCSK9)功能丧失突变的分子特征分析及复合杂合子的鉴定
Am J Hum Genet. 2006 Sep;79(3):514-23. doi: 10.1086/507488. Epub 2006 Jul 18.
8
Effect of mutations in the PCSK9 gene on the cell surface LDL receptors.前蛋白转化酶枯草溶菌素9(PCSK9)基因中的突变对细胞表面低密度脂蛋白(LDL)受体的影响。
Hum Mol Genet. 2006 May 1;15(9):1551-8. doi: 10.1093/hmg/ddl077. Epub 2006 Mar 28.
9
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.前蛋白转化酶枯草溶菌素9(PCSK9)的序列变异、低密度脂蛋白水平降低与冠心病预防
N Engl J Med. 2006 Mar 23;354(12):1264-72. doi: 10.1056/NEJMoa054013.
10
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.一系列前蛋白转化酶枯草溶菌素9(PCSK9)等位基因影响低密度脂蛋白胆固醇的血浆水平。
Am J Hum Genet. 2006 Mar;78(3):410-22. doi: 10.1086/500615. Epub 2006 Jan 20.

全长PCSK9在1.9埃分辨率下的自抑制结构揭示了其C端结构域与抵抗素的结构同源性。

The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain.

作者信息

Hampton Eric N, Knuth Mark W, Li Jun, Harris Jennifer L, Lesley Scott A, Spraggon Glen

机构信息

Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA 92121, USA.

出版信息

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14604-9. doi: 10.1073/pnas.0703402104. Epub 2007 Sep 5.

DOI:10.1073/pnas.0703402104
PMID:17804797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1976225/
Abstract

Mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9) are strongly associated with levels of low-density lipoprotein cholesterol in the blood plasma and, thereby, occurrence or resistance to atherosclerosis and coronary heart disease. Despite this importance, relatively little is known about the biology of PCSK9. Here, the crystal structure of a full-length construct of PCSK9 solved to 1.9-A resolution is presented. The structure contains a fully folded C-terminal cysteine-rich domain (CRD), showing a distinct structural similarity to the resistin homotrimer, a small cytokine associated with obesity and diabetes. This structural relationship between the CRD of PCSK9 and the resistin family is not observed in primary sequence comparisons and strongly suggests a distant evolutionary link between the two molecules. This three-dimensional homology provides insight into the function of PCSK9 at the molecular level and will help to dissect the link between PCSK9 and CHD.

摘要

前蛋白转化酶枯草溶菌素/九型(PCSK9)中的突变与血浆中低密度脂蛋白胆固醇水平密切相关,进而与动脉粥样硬化和冠心病的发生或抗性相关。尽管具有这种重要性,但人们对PCSK9的生物学特性了解相对较少。在此,展示了分辨率为1.9埃的PCSK9全长构建体的晶体结构。该结构包含一个完全折叠的富含半胱氨酸的C末端结构域(CRD),与抵抗素同三聚体具有明显的结构相似性,抵抗素是一种与肥胖和糖尿病相关的小细胞因子。在一级序列比较中未观察到PCSK9的CRD与抵抗素家族之间的这种结构关系,这强烈表明这两种分子之间存在遥远的进化联系。这种三维同源性为从分子水平深入了解PCSK9的功能提供了线索,并将有助于剖析PCSK9与冠心病之间的联系。